Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiaopi Granules and Decoction in TNBC
NCT06154109Phase 2Not yet recruiting
- Start
- Nov 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Xiaopi Formula in triple-negative breast cancer (TNBC). Planned start Nov 2023; status: not yet recruiting.
02
Drugs
Xiaopi Formula
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT06154109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06154109.